Foreseeing the Moments of Occurrence of Everolimus Long-term Side Effects by Follow up of Trough Blood Concentrations

Trial Profile

Foreseeing the Moments of Occurrence of Everolimus Long-term Side Effects by Follow up of Trough Blood Concentrations

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 05 Jun 2017

At a glance

  • Drugs Everolimus (Primary)
  • Indications Advanced breast cancer; Neuroendocrine tumours; Renal cell carcinoma
  • Focus Adverse reactions
  • Acronyms Foresight
  • Most Recent Events

    • 30 May 2017 Status changed from not yet recruiting to recruiting.
    • 22 Mar 2017 Planned primary completion date changed from 1 Jul 2018 to 1 Sep 2018.
    • 22 Mar 2017 Planned initiation date changed from 1 Mar 2017 to 1 May 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top